Biotech M&A spree buoys healthcare dealmakers before US conference
Last month alone, drugmakers including AbbVie, Bristol Myers Squibb and AstraZeneca announced about 25bn worth of transactions
New York — Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.
Kicking-off on Monday, the four-day JPMorgan Healthcare Conference is expected by organisers to attract more than 8,000 people, including delegations from the world’s largest drugmakers...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.